Statins Inhibit Rho Kinase Activity in Patients with Atherosclerosis

BACKGROUND: In addition to inhibiting cholesterol synthesis, statins (HMG-CoA reductase inhibitors) decrease the formation of isoprenoid intermediates required for the activation of key signaling pathways, including Rho/Rho kinase (ROCK). In experimental settings, statins inhibit ROCK and reverse va...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nohria, Anju, Prsic, Adnan, Liu, Ping-Yen, Okamoto, Ryuji, Creager, Mark A., Selwyn, Andrew, Liao, James K., Ganz, Peter
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2717178/
https://ncbi.nlm.nih.gov/pubmed/19167712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2008.12.023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky